ASSAY RECORD
Results
Showing up to 20 records.
| NO. | RECORD ID | NAME | SEQUENCE | SOURCE ORGANISM | FUNCTION CATEGORY | TARGET ORGANISM | ACTIVITY | ASSAY METHOD | PMID | PATENT NO | VERIFICATION STATUS |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 420081 | Rec_0432739 | Crustacean hyperglycemic hormone |
QIYDTSCKGVYDRGLFSDLEHVCDDCYNLYRNSYVASACRSNCYSNVVFRQCMEELLLMDEFDKYARAVQIV |
Cancer pagurus [Animal] |
Hyperglycemic, Metabolic regulation, Molting regulator, Hormone, Endocrine |
Cancer pagurus Y-organ |
- | in vitro ecdysteroid synthesis repression assay |
9809792 | - |
YES |
| 420082 | Rec_0432740 | TIMP-derived antiangiogenic peptide (SEQ ID NO:2) |
KITRCPMIPC |
synthetic construct [Synthetic] |
Anti-angiogenic |
capillary endothelial cells |
- | capillary endothelial cell proliferation assay |
- | US20020086420A1 |
YES |
| 420083 | Rec_0432741 | HHC82 |
KRKLIRWWW |
synthetic construct [Synthetic] |
Antimicrobial, Antibacterial |
Pseudomonas aeruginosa H1001 (fliC::luxCDABE) |
0.23 relative | luminescence assay relative IC50 |
- | US 9017656 B2 |
YES |
| 420084 | Rec_0432742 | RRM1-derived peptide / SEQ ID NO:436 |
QTETGTPYMLY |
synthetic construct [Synthetic] |
Anticancer immunotherapy, Tumor-associated antigen peptide, T-cell immunogenicity |
HLA-A*01-restricted human CD8+ T cells |
<20 % positive wells | In vitro CD8+ T-cell priming / pMHC multimer flow-cytometry assay |
- | CN110785183A |
YES |
| 420085 | Rec_0432743 | Oxy 271-287 |
EKKYFAATQFEPLAARL |
synthetic construct [Synthetic] |
HLA-DP4-binding, HLA class II reference peptide |
HLA-DPB1*04:02 |
10 nM | IC50 (HLA class II competitive peptide-binding assay) |
- | US 2011/0159022 A1 |
YES |
| 420086 | Rec_0432744 | Kassinin-like peptide K-I (PG-KI) |
QPHPDEFVGLM |
Pseudophryne guentheri [Animal] |
Tachykinin, Neuropeptide, Neuromodulator, Ion-transport stimulation |
frog skin epithelium; NK1-like tachykinin receptor |
- | Short-circuit current (SCC) ion-transport assay |
9809659 | - |
YES |
| 420087 | Rec_0432745 | Pse-Anal 1 |
WLNALKKVFQGIHEAIKLINNHVQ |
synthetic construct [Synthetic] |
Antimicrobial, Antibacterial, Antifungal |
Listeria monocytogenes KCTC 3710 |
32 μM | MIC |
30323036 | - |
YES |
| 420088 | Rec_0432746 | Pse-Anal 1 |
WLNALKKVFQGIHEAIKLINNHVQ |
synthetic construct [Synthetic] |
Antimicrobial, Antibacterial, Antifungal |
Pseudomonas aeruginosa ATCC 27853 |
16 μM | MIC |
30323036 | - |
YES |
| 420089 | Rec_0432747 | Pse-Anal 1 |
WLNALKKVFQGIHEAIKLINNHVQ |
synthetic construct [Synthetic] |
Antimicrobial, Antibacterial, Antifungal |
Trichosporon beigelii KCTC 7707 |
64 μM | MIC |
30323036 | - |
YES |
| 420090 | Rec_0432748 | Pse-Anal 1 |
WLNALKKVFQGIHEAIKLINNHVQ |
synthetic construct [Synthetic] |
Antimicrobial, Antibacterial, Antifungal |
Staphylococcus aureus CCARM 3518 |
32 μM | MIC |
30323036 | - |
YES |
| 420091 | Rec_0432749 | Pse-Anal 1 |
WLNALKKVFQGIHEAIKLINNHVQ |
synthetic construct [Synthetic] |
Antimicrobial, Antibacterial, Antifungal |
Staphylococcus aureus CCARM 3090 |
32 μM | MIC |
30323036 | - |
YES |
| 420092 | Rec_0432750 | Pse-Anal 1 |
WLNALKKVFQGIHEAIKLINNHVQ |
synthetic construct [Synthetic] |
Antimicrobial, Antibacterial, Antifungal |
Escherichia coli CCARM 1229 |
16 μM | MIC |
30323036 | - |
YES |
| 420093 | Rec_0432751 | Pse-Anal 1 |
WLNALKKVFQGIHEAIKLINNHVQ |
synthetic construct [Synthetic] |
Antimicrobial, Antibacterial, Antifungal |
Escherichia coli CCARM 1238 |
16 μM | MIC |
30323036 | - |
YES |
| 420094 | Rec_0432752 | Pse-Anal 1 |
WLNALKKVFQGIHEAIKLINNHVQ |
synthetic construct [Synthetic] |
Antimicrobial, Antibacterial, Antifungal |
Pseudomonas aeruginosa 4007 |
16 μM | MIC |
30323036 | - |
YES |
| 420095 | Rec_0432753 | Pse-Anal 1 |
WLNALKKVFQGIHEAIKLINNHVQ |
synthetic construct [Synthetic] |
Antimicrobial, Antibacterial, Antifungal |
Pseudomonas aeruginosa 4891 |
16 μM | MIC |
30323036 | - |
YES |
| 420096 | Rec_0432754 | Pse-Anal 1 |
WLNALKKVFQGIHEAIKLINNHVQ |
synthetic construct [Synthetic] |
Cytotoxic |
HaCaT human keratinocytes |
98.2 % cytotoxicity | Cytotoxicity assay (100 μM peptide exposure) |
30323036 | - |
YES |
| 420097 | Rec_0432755 | Pse-Anal 1 |
WLNALKKVFQGIHEAIKLINNHVQ |
synthetic construct [Synthetic] |
Cytotoxic |
HaCaT human keratinocytes |
98.2 % | Cytotoxicity assay (100 μM peptide exposure) |
30323036 | - |
YES |
| 420098 | Rec_0432756 | Unnamed |
QTETGTPYMLY |
synthetic construct [Synthetic] |
MHC class I binding, Anticancer |
HLA-A*01 |
>75 % | MHC class I peptide-exchange binding assay |
- | CN110785183A; US20220162277A1 |
YES |
| 420099 | Rec_0432757 | Unnamed |
FLDPNARPLV |
synthetic construct [Synthetic] |
MHC class I binding, Anticancer |
HLA-A*02 |
>75 % | MHC class I peptide-exchange binding assay |
- | CN110785183A; US20220162277A1 |
YES |
| 420100 | Rec_0432758 | Kassinin-like peptide K-I (PG-KI) |
QPHPDEFVGLM |
Pseudophryne guentheri [Animal] |
Tachykinin, Neuropeptide, Receptor modulation |
frog skin NK1-like tachykinin receptor |
- | frog-skin short-circuit current ion-transport bioassay |
9809659 | - |
YES |